BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors

Summary

Phase I trial to study the effectiveness of BMS-214662 plus trastuzumab in treating patients who have advanced solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Combining monoclonal antibody therapy with chemotherapy may kill more tumor cells

Timeline

Start

2001-07

Primary completion

2004-01

Completion

—

Drugs

Indications